MDT Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

78.550

Open

78.550

VWAP

77.92

Vol

2.94M

Mkt Cap

100.91B

Low

77.550

Amount

228.72M

EV/EBITDA(TTM)

12.04

Total Shares

1.28B

EV

120.81B

EV/OCF(TTM)

16.59

P/S(TTM)

--

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

Show More

Events Timeline

(ET)

2026-05-21

07:10:00

Covalon Q2 Revenue Grows 15% Year-over-Year to $8.7M

2026-05-20 (ET)

2026-05-20

09:20:00

Medtronic Plans to Acquire SPR Therapeutics for $650 Million

2026-04-30 (ET)

2026-04-30

10:00:00

Orchestra BioMed Receives Second Breakthrough Device Designation from FDA

2026-04-30

07:20:00

Teleflex Appoints Jason Weidman as New CEO

2026-04-26 (ET)

2026-04-26

22:00:00

Sun Pharma to Acquire Organon for $14 Per Share

2026-04-26

13:50:00

Medtronic's Sphere-9 Catheter Receives FDA Breakthrough Device Designation

News

NASDAQ.COM

05-22NASDAQ.COM

Biotech Sector Regulatory Approvals and Collaborations

seekingalpha

05-20seekingalpha

Medtronic to Acquire SPR Therapeutics for $650M to Enhance Neuroscience Portfolio

PRnewswire

05-20PRnewswire

Medtronic to Acquire SPR Therapeutics, Enhancing Neuromodulation Portfolio

Newsfilter

05-20Newsfilter

Medtronic Acquires SPR to Enhance Neuromodulation Technology

Fool

Analysis of High Dividend Stocks in Healthcare Sector

NASDAQ.COM

05-19NASDAQ.COM

Analysis of High Dividend Performance in Healthcare Stocks

20 Analyst Rating

Wall Street analysts forecast MDT stock price to rise

11 Buy

9 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

102.00

Averages

111.76

High

120.00

Current: 0.000

Low

102.00

Averages

111.76

High

120.00

Jefferies

Matthew Taylor

Hold

downgrade

$108 -> $95

AI Analysis

2026-04-23

Reason

Jefferies

Matthew Taylor

Price Target

$108 -> $95

AI Analysis

2026-04-23

downgrade

Hold

Reason

Jefferies analyst Matthew Taylor lowered the firm's price target on Medtronic (MDT) to $95 from $108 and keeps a Hold rating on the shares. The firm updated its FY26 EPS outlook to reflect MiniMed (MMED) IPO timing and one-time expenses for Minimed Flex. Jefferies added that Medtronic's announced one-time $157M charge in Q4 related to the present value of future payments owed to Blackstone for the MiniMed Flex launch added to the EPS guide revision.

UBS

Neutral

downgrade

$104 -> $90

2026-04-22

Reason

UBS

Price Target

$104 -> $90

2026-04-22

downgrade

Neutral

Reason

UBS lowered the firm's price target on Medtronic to $90 from $104 and keeps a Neutral rating on the shares. The firm updated its model to reflect the diabetes separation.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MDT

Unlock Now

Valuation Metrics

The current forward P/E ratio for Medtronic PLC (MDT.N) is 12.89, compared to its 5-year average forward P/E of 16.70. For a more detailed relative valuation and DCF analysis to assess Medtronic PLC's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

5Y Average PE

16.70

Current PE

12.89

Overvalued PE

18.99

Undervalued PE

14.41

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

5Y Average EV/EBITDA

14.21

Current EV/EBITDA

11.81

Overvalued EV/EBITDA

15.96

Undervalued EV/EBITDA

12.47

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

3.63

Current PS

2.64

Overvalued PS

4.28

Undervalued PS

2.98

Financials

AI Analysis

Annual

Quarterly

Whales Holding MDT

Dakota Wealth, LLC

Citadel Advisors LLC

Argenta Asset Management SA

SG Americas Securities, LLC

GuideStone Capital Management, LLC

Crossmark Global Investments, Inc.

Trading Trends

People Also Watch

Frequently Asked Questions

What is Medtronic PLC (MDT) stock price today?

The current price of MDT is 77.65 USD — it has decreased -1.21

What is Medtronic PLC (MDT)'s business?

Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.

What is the price predicton of MDT Stock?

Wall Street analysts forecast MDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MDT is111.76 USD with a low forecast of 102.00 USD and a high forecast of 120.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Medtronic PLC (MDT)'s revenue for the last quarter?

Medtronic PLC revenue for the last quarter amounts to 9.02B USD, increased 8.74

What is Medtronic PLC (MDT)'s earnings per share (EPS) for the last quarter?

Medtronic PLC. EPS for the last quarter amounts to 0.89 USD, decreased -11.88

How many employees does Medtronic PLC (MDT). have?

Medtronic PLC (MDT) has 95000 emplpoyees as of May 26 2026.

What is Medtronic PLC (MDT) market cap?

Today MDT has the market capitalization of 100.91B USD.